RNA, U6 small nuclear 178, pseudogene (RNU6-178P)

RNU6-178P is a **processed pseudogene** derived from the **U6 small nuclear RNA (snRNA) gene**, cataloged as a non-coding element in the human genome[2][6]. The parental gene, U6 snRNA, is an essential non-coding RNA that participates in pre-mRNA splicing as a core part of the spliceosome, but this pseudogene variant (RNU6-178P) **does not produce a functional RNA** and is considered biologically inactive[2][6][7].\nPseudogenes of U6 (including RNU6-178P) form via **L1 (LINE-1)-mediated retrotransposition**, where retrotransposon activity results in the insertion of non-functional RNA gene copies into the genome. These pseudogenes are widespread and serve as historical markers of retrotransposition but are not known to have a direct role in normal physiology or disease, nor do they act as molecular targets for drugs or therapeutic intervention[7][1][2].\nUnlike canonical U6 snRNA genes, RNU6-178P and related pseudogenes are unexpressed, do not participate in the spliceosome, and are not considered receptors, enzymes, or drug targets[2][6].\n\n**Key points:**\n- RNU6-178P is a **pseudogene**, not a protein-coding gene or functional RNA, and is not a therapeutic target[2][6][7].\n- It is one of many U6 snRNA-derived pseudogenes in the human genome, generated through retrotransposition[1][7].\n- The functional, canonical U6 snRNA (not the pseudogene) is vital for mRNA splicing, but RNU6-178P has no current biological or therapeutic relevance[2][5][6].\n\nNo evidence suggests the existence of approved or investigational drugs, clinical safety concerns, biomarker applications, or roles in human disease for RNU6-178P or other U6 pseudogenes[2][6][7].

Other names

RNU6-178P